A012301: LOTAM: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early Stage Breast Cancer
- Title
- LOTAM: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-risk Early Stage Breast Cancer
- Principal Investigator
- Jiang, Bei
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Breast Cancer
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Valli White, RN
- Research Nurse
- Phone: +1 304-264-1220
- Email: valli.white@wvumedicine.org
- Melissa Boggess, RN
- Research Nurse
- Phone: +1 304-487-7515
- Email: melissa.boggess1@wvumedicine.org
- Maher Kali, MD
- Clinical Research Specialist-WVUCI
- Phone: +1 304-243-7045
- Email: maher.kali@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org
- Kaitlyn Hager
- Research Nurse
- Email: kaitlyn.hager@hsc.wvu.edu